30 closest matches · ranked by relevance
Marijuana Dependence
Primary: Mean Delivered and Retained Doses — 0.016; 0.018; 0.026 grams (g)
Smoking · Tobacco Use
Primary: Choices to Smoke — 26.15; 30; 38.33 Percentage of Total Choices
Cigarette Smoking · Tobacco Use
Primary: Contextual Factors Associated With Tobacco Use Episode Reported Via Ecological Momentary Assessment — 3; 22; 11; 12 tobacco use episodes — p=0.002
E-cigarette Use
Primary: Plasma Nicotine Concentration — 0.78; 1.08; 0.89; 1.16 ng/ml
E-cigarette Use · Vaping
Primary: Participant Recruitment and Retention — 37; 31 Participants
Energy Intake · Food Intake · E-Cig Use
Primary: Energy Intake — 1102.1; 1003.4; 910.4; 868.3 Kilocalories
Vaping Behaviors
Primary: Mean Vaping Quit Intentions Score — 2.5; 2.5; 2.2 score on a scale — p=<.001
Electronic Cigarette Use
Primary: Plasma Nicotine Concentration — 2.00; 1.92; 1.64; 1.62 mg/ml
Electronic Cigarettes
Primary: Change in Plasma Nicotine — 8.68; 8.28; 9.53; 12.00 ng/ml
Nicotine Dependence · E-Cig Use
Primary: 7-day Point Prevalence Vaping Abstinence — 55; 54; 61; 59 Participants — p=0.14
Tobacco Use Disorder
Primary: Number of Cigarettes Smoked Per Day — 2.2; 1.8; 6.0; 7.1 model estimated cigarettes per day
Nicotine Dependence · Nicotine Addiction · Nicotine Use Disorder
Primary: Overall Treatment Satisfaction Rating — 3.8 units on a scale
Smoking, Cigarette · Smoking, Tobacco · Nicotine Dependence
Primary: Complete Change From Conventional Cigarettes - Self Report — 0; 12; 10; 0 Participants
Smoking · Tobacco Use
Primary: Mean Cigarettes Per Day — 13.1; 12.6; 12.2; 13.3 cigarettes per day
Vaping · Nicotine Dependence
Primary: Continuous 4-week Nicotine Vaping Abstinence at End of Treatment (Weeks 9-12) — 45; 12; 5 Participants — p=<0.001
Smoking, Cigarette
Primary: Proportion of Participants With Self-Reported 7-day Point Prevalence Abstinence From Cigarettes — 41; 33 Participants
Behavior, Health Risk · Implementation Science · E Cigarette Use
Primary: Engagement_remote checkin_3 — 6; 5; 6; 5 Participants — p=0.820
Smoking
Primary: Cigarette Use — -1.82 cigarettes
Vaping
Primary: Change in Percentage of Participants Susceptible to Future Vaping — 1.1; -5.7; -2.3; -3.2 percentage of participants
E-Cig Use
Primary: Attention to Specific ad Feature — -1.7062; -0.9676; -1.8238 Beats per minute
Smoking Cessation
Primary: Total Inhaled Volume — 416.5; 490.3 mL
Electronic Cigarettes
Primary: Plasma Nicotine Concentration — 12.32; -0.22; 7.09; 5.85 ng/ml
Vaping
Primary: Mean Susceptibility to Vaping Score — 2.16; 2.21; 2.36 score on a scale
Cigarette Smoking Behavior
Primary: Nicotine/Tobacco Products Substitution — 1326.25; 206; 120.83; 46.79 mg of nicotine purchased
Electronic Cigarette Use
Primary: Effort for Product Puffs With Cross Product Progressive Ratio Task (CP-PRT) — 6.30; 6.38; 6.34; 5.94 Breakpoint (highest trial completed)
Vaping Behavior
Primary: Mean Susceptibility to Vaping Score — 1.91; 1.82 score on a scale
Nicotine Dependence
Primary: Changes in Liking of E-cigarette Overall — 14.2; 5.3; 11.9; 2.2 score on a scale — p=0.01
Electronic Nicotine Delivery System Flavors
Primary: Average Daily Cigarette Use — 10.3; 17.3; 12.3; 5.3 number of cigarettes per day
Electronic Cigarettes
Primary: Change in Plasma Nicotine — 7.62; 10.65; 18.31; 7.19 ng/ml
Cigarette Smoking · Smoking Behaviors
Primary: Puff Topography — 1108; 1045.2; 1084.6 mL